Therapure Biopharma Inc.

Therapure Biopharma Inc. Announces Collaboration With Induce Biologics Inc.

    Toronto, Canada (ots/PRNewswire) -

    - Ontario Biotech Companies Work Together on Innovative Bone Protein  Technology

TORONTO, Canada, October 28 /PRNewswire/ --

    Thomas Wellner, President and CEO of Therapure BioPharma Inc. and Dr.  Cameron Clokie, President and CEO of Induce Biologics Inc. today announced  a development partnership utilizing an innovative approach to the  production and manufacture of selected growth factors for stimulating bone  regeneration. Such growth factors are critical tools used in regenerative  medicine, with particular applications in the regeneration of the skeleton.

    Therapure will apply its experience and knowledge in cell culture and  in the design and development of scaled-up biologic manufacturing processes  to advance the initial research and development conducted by Induce. The  technology is a result of over 10 years of research and development by the  founders of Induce in the areas of bone regeneration and the development of  growth factor containing bone grafts.

    "Induce's technology is a tremendous example of the creativity and  innovation that exists in Ontario," said Thomas Wellner. "We are very  pleased that they have chosen Therapure Biopharma as their partner for the  further development of this important new technology and we look forward to  working with them to bring this product to a global market."

    "Our technology was invented in Canada", said Cameron Clokie, "and we  are excited to have found a company in Ontario that is capable of working  with us to further develop this technology. We are pleased that Therapure  Biopharma is as eager as we are to make this technology available to  patients world-wide."

    About Therapure Biopharma:

    Therapure Biopharma Inc. is an integrated biopharmaceutical company  that develops, manufactures, purifies, and packages therapeutic proteins.  Therapure Biopharma acquired its Canadian-built and conceived facility from  Hemosol Corporation, a specialist in therapies derived from hemoglobin, a  blood protein. Therapure Biopharma applies scientific, manufacturing, and downstream purification expertise with an intimate understanding of advanced biology, complex proteins, and regulatory processes to develop  effective and innovative solutions to advance products from discovery to  market.

    For more information, please visit: http://www.therapurebio.com

    About Induce Biologics Inc.:

    Induce Biologics Inc was founded in 2008 to develop and commercialize  technologies invented at the University of Toronto. Induce Biologics' goal  is to utilize these technologies along with others being developed  internally to create cost effective growth factor containing bone grafts  for mammalian skeletal regeneration.

    For further information: Media Contact: Thomas Wellner, President and  CEO, Therapure Biopharma Inc., +1-905-286-6204, ceo@therapurebio.com/

ots Originaltext: Therapure Biopharma Inc
Im Internet recherchierbar: http://www.presseportal.ch

Contact:
For further information: Media Contact: Thomas Wellner, President and
CEO, Therapure Biopharma Inc., +1-905-286-6204, ceo@therapurebio.com/



Weitere Meldungen: Therapure Biopharma Inc.

Das könnte Sie auch interessieren: